Terms: = Breast cancer AND HOXC13, HOX3G, 3229, ENSG00000123364, P31276, HOX3
9 results:
1. Piperazin incorporated Schiff Base derivatives: Assessment of in vitro biological activities, metabolic enzyme inhibition properties, and molecular docking calculations.
Mermer A; Tüzün B; Daştan SD; Koçyiğit ÜM; Çetin FN; Çevik Ö
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23465. PubMed ID: 37462216
[TBL] [Abstract] [Full Text] [Related]
2. Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China.
Zhang YB; Pan XF; Lu Q; Wang YX; Geng TT; Zhou YF; Liao LM; Tu ZZ; Chen JX; Xia PF; Wang Y; Wan ZZ; Guo KQ; Yang K; Yang HD; Chen SH; Wang GD; Han X; Wang YX; Yu D; He MA; Zhang XM; Liu LG; Wu T; Wu SL; Liu G; Pan A
Diabetologia; 2022 Dec; 65(12):2044-2055. PubMed ID: 36102938
[TBL] [Abstract] [Full Text] [Related]
3. Underutilization of Needle Biopsy Before breast Surgery: A Measure of Low-Value Care.
Gilmore RC; Wang P; Kaczmarski K; Hutfless S; Euhus DM; Jacobs LK; Habibi M; Lange J; Camp M; Makary MA
Ann Surg Oncol; 2021 May; 28(5):2485-2492. PubMed ID: 33512674
[TBL] [Abstract] [Full Text] [Related]
4. Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Saura C; Hlauschek D; Oliveira M; Zardavas D; Jallitsch-Halper A; de la Peña L; Nuciforo P; Ballestrero A; Dubsky P; Lombard JM; Vuylsteke P; Castaneda CA; Colleoni M; Santos Borges G; Ciruelos E; Fornier M; Boer K; Bardia A; Wilson TR; Stout TJ; Hsu JY; Shi Y; Piccart M; Gnant M; Baselga J; de Azambuja E
Lancet Oncol; 2019 Sep; 20(9):1226-1238. PubMed ID: 31402321
[TBL] [Abstract] [Full Text] [Related]
5. hoxc13-AS promotes breast cancer cell growth through regulating miR-497-5p/PTEN axis.
Li X; Wang Q; Rui Y; Zhang C; Wang W; Gu J; Tang J; Ding Y
J Cell Physiol; 2019 Dec; 234(12):22343-22351. PubMed ID: 31066051
[TBL] [Abstract] [Full Text] [Related]
6. Metabolic Profiling of Dietary Polyphenols and Methylxanthines in Normal and Malignant Mammary Tissues from breast cancer Patients.
Ávila-Gálvez MÁ; García-Villalba R; Martínez-Díaz F; Ocaña-Castillo B; Monedero-Saiz T; Torrecillas-Sánchez A; Abellán B; González-Sarrías A; Espín JC
Mol Nutr Food Res; 2019 May; 63(9):e1801239. PubMed ID: 30690879
[TBL] [Abstract] [Full Text] [Related]
7. MUC1-C activates BMI1 in human cancer cells.
Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
[TBL] [Abstract] [Full Text] [Related]
8. Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With breast cancer: A Population-Based Survey.
Freedman RA; Kouri EM; West DW; Rosenberg S; Partridge AH; Lii J; Keating NL
Clin Breast Cancer; 2016 Apr; 16(2):105-12. PubMed ID: 26410475
[TBL] [Abstract] [Full Text] [Related]
9. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
[TBL] [Abstract] [Full Text] [Related]
